Vitamin D status and risk of cardiovascular events: Lessons learned via systematic review and meta-analysis

Cardiology in Review

Volumn 19, Issue 4, 2011, Pages 192-201

  Sokol, Seth I ^a   Tsang, Pansy ^b   Aggarwal, Vikas ^c   Melamed, Michal L ^a   Srinivas, V S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JACOBI MEDICAL CENTER   (United States)

Author keywords

cardiovascular events; meta analysis; systematic review; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; EMBASE; FOLLOW UP; HUMAN; MEDLINE; OUTCOME ASSESSMENT; REVIEW; RISK FACTOR; RISK REDUCTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

CARDIOVASCULAR DISEASES; CONFIDENCE INTERVALS; DIETARY SUPPLEMENTS; HUMANS; RISK; RISK FACTORS; RISK REDUCTION BEHAVIOR; STATISTICS AS TOPIC; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 79959220177     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31821da9a5     Document Type: Review

References (33)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics - 2010 update. A report from the American Heart Association. Circulation. 2010;121:e46-e215.
2. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009;4:1515-1522.
3. Kendrick J, Targher G, Smits G, et al. 25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2009;205:255-260.
4. Kim DH, Sabour S, Sagar UN, et al. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 2008;102:1540-1544.
5. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52:1949-1956.
6. Levin A, Li YC. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005;68:1973-1981. (Pubitemid 43117772)
7. Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89-90:387-392. (Pubitemid 38844316)
8. Talmor Y, Bernheim J, Klein O, et al. Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro. Eur J Clin Invest. 2008;38:548-554. (Pubitemid 352019134)
9. Talmor Y, Golan E, Benchetrit S, et al. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol. 2008;294:F1059-F1064.
10. Wu-Wong JR, Nakane M, Ma J, et al. Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis. 2006;186:20-28.
11. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
12. Ross AC, Taylor CL, Yaktine AL, et al, eds; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine 2010. Dietary reference intakes for calcium and vitamin D. Available at: http://www.iom.edu/ Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx. Accessed February 2011.
13. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169:626-632.
14. Wang L, Manson JE, Song Y, et al. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152:315-323.
15. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin d and cardiometabolic outcomes. Ann Intern Med. 2010;152:307-314.
16. Rollins G. Vitamin D testing - what's the right answer? Labs grapple with confusing analytics, evidence. Clin Lab News. 2009;35(7 sect 1):6-9.
17. Vitamin D and omega-3 fish oil to be the focus of new $20 million study. In: Nutrition Business Journal. 2009. Available at: http:// nutritionbusinessjournal. com/supplements/news/0623-vitamin-d-omega-fish-oil- focus-new-20-million-dollar-study/index.html.
18. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012. (Pubitemid 30214957)
19. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(suppl 3):21-35. (Pubitemid 33732964)
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188. (Pubitemid 17189972)
21. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. (Pubitemid 37088507)
22. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
23. Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008; 168:1174-1180. (Pubitemid 351831400)
24. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340-1349. (Pubitemid 351930842)
25. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008; 93:3927-3935.
26. Ginde AA, Scragg R, Schwartz RS, et al. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009;57:1595-1603.
27. Melamed ML, Michos ED, Post W, et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629-1637.
28. Semba RD, Houston DK, Bandinelli S, et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr. 2010;64:203-209.
29. Kilkkinen A, Knekt P, Aro A, et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009;170:1032-1039.
30. Pilz S, Dobnig H, Nijpels G, et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf). 2009;71:666-672.
31. Bolland MJ, Bacon CJ, Horne AM, et al. Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr. 2010;91:82-89.
32. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503-511.
33. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010;65:225-236.